Semaglutide

Hold

Techniques

A GLP-1 receptor agonist drug used for diabetes and weight management.

Why it's here

Placed in Hold: 1 article(s) of evidence from 1 source(s), led by research-stage coverage, with 0 in the last 30 days. Confidence 24%. Low accumulated evidence, so it defaults conservatively pending more signal.

Evidence (1)

5Hacker News·8/15/2026research
Semaglutide linked to lower predicted dementia risk
A study reported that semaglutide use was associated with a lower predicted risk of dementia. The finding is based on research analysis rather than a clinical proof of prevention, so it should be interpreted as an association, not a confirmed causal effect.